IP Library Granted Patent US 7,678,896
Granted Patent B2
US 7,678,896 · App. 11/818,938 · Granted Mar 16, 2010

siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,678,896
App. No.
11/818,938
Granted
Mar 16, 2010
Kind
B2
Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to STK12.

Claims (17)

1. An siRNA molecule consisting of: (a) a sense region and an antisense region, wherein said sense region and said antisense region together form a duplex region consisting of 19-30 base pairs and said antisense region comprises a sequence that is the complement of SEQ ID NO: 490; and (b) either no overhang regions or at least one overhang region, wherein each overhang region is six or fewer nucleotides in length.

2. The siRNA molecule of claim 1 , wherein said antisense region and said sense region are each 19-25 nucleotides in length.

3. The siRNA molecule of claim 2 , wherein said antisense region and said sense region are each 19 nucleotides in length.

4. The siRNA molecule of claim 1 , wherein said siRNA molecule has at least one overhang region.

5. The siRNA molecule of claim 1 , wherein said siRNA molecule has no overhang regions.

6. The sIRNA molecule of claim 2 , wherein said siRNA molecule has at least one overhang region.

7. The siRNA molecule of claim 2 , wherein said siRNA molecule has no overhang regions.

8. The siRNA molecule of claim 3 , wherein said siRNA molecule has at least one overhang region.

9. The siRNA molecule of claim 3 , wherein said siRNA molecule has no overhang regions.

10. A chemically synthesized double stranded siRNA molecule that directs cleavage of an mRINA via RNA interference, wherein:

(a) each strand of said double stranded siRNA molecule is between 19 and 30 nucleotides in length; and

(b) one strand of said double stranded siRNA molecule comprises a sequence that is the complement of SEQ ID NO: 490.

11. The chemically synthesized double stranded siRNA molecule of claim 10 , wherein each strand of said double stranded siRNA molecule is 19 nucleotides in length.

12. An siRNA molecule, wherein said siRNA molecule consists of: p 1 (a) a sense region, wherein said sense region consists of a sequence that is SEQ ID NO: 490, and an antisense region, wherein said antisense region consists of a sequence that is the complement of SEQ ID NO: 490; and (b) either no overhang regions or at least one overhang region, wherein each overhang region is six or fewer nucleotides in length.

13. The siRNA molecule of claim 12 , wherein said siRNA molecule has no overhang regions.

14. The siRNA molecule of claim 12 , wherein said siRNA molecule has one overhang region.

15. The siRNA molecule of claim 12 , wherein said siRNA molecule has two overhang regions.

Assignments (3)
CHANGE OF NAME Recorded May 22, 2014
From: DHARMACON, INC.
To: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
Reel/Frame 032997/0215 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2014
From: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
To: THERMO FISHER SCIENTIFIC INC.
Reel/Frame 032723/0415 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2007
From: KHVOROVA, ANASTASIA; REYNOLDS, ANGELA; LEAKE, DEVIN; MARSHALL, WILLIAM; READ, STEVEN; SCARINGE, STEPHEN
To: DHARMACON, INC.
Reel/Frame 019507/0219 →